Inverse association between DPP-4 inhibitor use and fracture in older adults: A disproportionality analysis of the FAERS and JADER
Int. Journal of Clinical Pharmacology and Therapeutics · 2023
DOI: 10.5414/cp204266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2023. Verfasst von Katsuhiro Ohyama und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dipeptidyl-Peptidase IV Inhibitors, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Ohyama, K., Okamoto, T., & Hori, Y. (2023). Inverse association between DPP-4 inhibitor use and fracture in older adults: A disproportionality analysis of the FAERS and JADER. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204266
Vancouver
Ohyama K, Okamoto T, Hori Y. Inverse association between DPP-4 inhibitor use and fracture in older adults: A disproportionality analysis of the FAERS and JADER. Int. Journal of Clinical Pharmacology and Therapeutics. 2023. doi:10.5414/cp204266
BibTeX
@article{Ohyama2023,
author = {Ohyama, Katsuhiro and Okamoto, Takumi and Hori, Yusuke},
title = {Inverse association between DPP-4 inhibitor use and fracture in older adults: A disproportionality analysis of the FAERS and JADER},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2023},
doi = {10.5414/cp204266}
}
EUVIMED